Autologous Tolerogenic Dendritic Cells therapy(Fundacio Clinic Per A La Recerca Biomédica)

N/A

Report date: 2025/03/04 20:00:11

Base Information

Drug NameAutologous Tolerogenic Dendritic Cells therapy(Fundacio Clinic Per A La Recerca Biomédica)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy
Mechanisms of ActionDendritic cells modulators
TargetsUpdating
Therapy Area/IndicationsRejection of renal transplantationColorectal Neoplasms, Hereditary Nonpolyposis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesFundacio Clinic Per A La Recerca Biomédica
China Registration ClassN/A

Develop Information

Active CompaniesFundacio Clinic Per A La Recerca Biomédica
Inactive CompaniesN/A
Active IndicationsRejection of renal transplantationColorectal Neoplasms, Hereditary Nonpolyposis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A